Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EP BiocompositesBOM:543595 76 EBITDA Margin % is 21.55% as of Mar. 2026, which is 37% above its 10-year median of 15.69. GuruFocus rates BOM:543595 with a GF Score™ of 76/100 and a GF Value™ of ₹201.91 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 1,767 Construction companies, EP Biocomposites ranks better than 78.95% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. EP Biocomposites's EBITDA for the
six
months ended in Mar. 2026 was ₹20.6 Mil. EP Biocomposites's Revenue for the
six
months ended in Mar. 2026 was ₹95.7 Mil. Therefore, EP Biocomposites's EBITDA margin for the quarter that ended in Mar. 2026 was 21.55%.
EP Biocomposites (BOM:543595) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
EP Biocomposites EBITDA Margin % Related Terms
EP Biocomposites EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for EP Biocomposites's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543595 vs TT, JCI, CARR: EBITDA Margin % Comparison
For the Building Products & Equipment subindustry, EP Biocomposites's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EP Biocomposites EBITDA Margin % vs Construction Industry
For the Construction industry and Industrials sector, EP Biocomposites's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where EP Biocomposites's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EP Biocomposites (BOM:543595) has a EBITDA Margin % of 21.55% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on EP Biocomposites and its competitors. This is 37% above median its historical median of 15.69. Over the past decade, EP Biocomposites' EBITDA Margin % has ranged from 7.59 to 17.44. According to the industry distribution chart, EP Biocomposites ranks #372 out of 1767 companies in the Construction industry, placing it in the top 21.1%.
Is EP Biocomposites' EBITDA Margin % too high?
EP Biocomposites' current EBITDA Margin % of 21.55% is 37% above median its 10-year median of 15.69. Over the past 10 years, this metric has ranged from a low of 7.59 to a high of 17.44. The Construction industry median EBITDA Margin % is 9.17. EP Biocomposites' value of 21.55% is 135% above this industry median. Based on the distribution chart, EP Biocomposites ranks #372 out of 1767 companies in the Construction industry, which is in the top quartile — a strong position relative to peers. Overall, EP Biocomposites has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EP Biocomposites' EBITDA Margin % compare to TT and JCI?
According to the Construction industry distribution chart, EP Biocomposites ranks #372 out of 1767 companies for EBITDA Margin %. This places EP Biocomposites in the top 21% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 9.17. EP Biocomposites' value of 21.55% is 135% above this benchmark. Historically, EP Biocomposites' own EBITDA Margin % has ranged from 7.59 to 17.44 over the past decade. While the company's 10-year median is 15.69 vs. the industry median of 9.17, EP Biocomposites has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Construction company?
The median EBITDA Margin % among Construction companies is 9.17, based on 1,767 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EP Biocomposites's current EBITDA Margin % of 21.55% is 135% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on EP Biocomposites and its competitors. For the Construction industry, the median EBITDA Margin % is 9.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EP Biocomposites's current EBITDA Margin % is 21.55%, which is 37% above median its own 10-year median of 15.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EP Biocomposites stock overvalued right now?
Based on GuruFocus' analysis, EP Biocomposites (BOM:543595) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹201.91, compared to a current price of ₹106.00 — trading 47.5% below its estimated fair value. The current EBITDA Margin % is 21.55%, which is 37% above median its 10-year median of 15.69 and 135% above the Construction industry median of 9.17. EP Biocomposites' overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For EP Biocomposites (BOM:543595), the current EBITDA Margin % is 21.55% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EP Biocomposites (BOM:543595) Overvalued in 2026?
Based on GuruFocus' analysis, EP Biocomposites stock appears to be undervalued.
The current stock price of ₹106.00 is trading 47.5% below its estimated GF Value™ of ₹201.91.
GuruFocus considers EP Biocomposites to be Significantly Undervalued.
Key valuation signals for BOM:543595:
EBITDA Margin %: 21.55% (37% above median its 10-year median of 15.69)
GF Value™: ₹201.91 vs. price of ₹106.00 (47.5% below fair value)
Industry Position: 135% above the Construction median (#372 of 1767)
No single metric tells the full story. See the BOM:543595 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EP Biocomposites Ltd is the manufacturer and supplier of fibre reinforced polymers products such as door shutters, frames, Biodigestor Tanks, Bio toilets and allied products for construction and Industrial applications. The company focus on giving sanitation solutions to those who do not have access to toilets, as well as to those who have toilets but face trouble treating and managing the waste through septic tanks. The company also provides sanitation infrastructure and human waste management solutions and services, involving simple bio-digester technology licensed from the Defence Research and Development Organisation (DRDO) and Industry Interface and Technology Management, operating under the aegis of DRDO, Ministry of Defence, Government of India.
76GF Score
Get the complete analysis for BOM:543595
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543595 has been successfully added to your 
